Skin Enhancement Clinics & Technology Inc. (Pink Sheets: SCTG) ("SECT") (www.aestheticimages.md) is a publicly traded company with the trading symbol of "SCTG." Tim Connelly, chairman of the board of directors, is pleased to announce the following developments during the first quarter of 2005:
-- SECT is on schedule for opening its first full-service Medi-Spa. That Medi-Spa will be located at 2275 S. Main St., Corona, CA 92882. A lease for 4,665 square feet in a new commercial office building located in the heart of Corona was executed on Jan. 31, 2005. The term of the lease is for five years with an option to renew for an additional five years.
-- The Fox Group, LLC, professional consultants to the health care industry, located in Upland, Calif., was retained by SECT in November 2004 to conduct a demographic study of the Southern California area to determine the most suitable location for SECT's first Medi-Spa. The Corona/Norco area was eventually selected based upon several positive indicators such as lack of competition, average income of the families living in that area, explosive growth of upscale families in the area, etc.
-- Once the location was secured, SECT retained Beautiful Forever Consulting Firm Inc. in New Jersey, a nationally renowned consulting firm specializing in medical spas, to assist management with the design of the facility and the refinement of the products and services to be offered to patrons.
-- The Wirt Design Group Inc., a nationally prominent interior design group located in Los Angeles (www.wirtdesign.com), was also retained to assist SECT's management with the interior design and with 3-D modeled renderings and virtual tours of the space.
-- Michael Barrett, AIA, an architect, is working in harmony with these consultants and with SECT's general contractor to complete the working drawings for the first facility.
-- During the interim, Dr. Brett Lehocky, a board-certified plastic surgeon and SECT's medical director, is interviewing vendors for equipment and supplies. He is also working closely with the medical staff to establish protocols and procedures for the Medi-Spa to ensure full compliance with all state and/or national regulatory guidelines regarding Medi-Spas and to maximize the quality of service and care to patrons.
-- SECT completed its 2004 Disclosure Statement and its audited financial statements for 2003-04, which can be viewed on the Pink Sheets Web site (www.pinksheets.com) at the company's ("SCTG") information page by clicking on the tab "Financial Reports."
For further information regarding SECT, contact Jamie Gorbenko, VP of marketing, at SECT's executive offices located at 630 Newport Center Drive, Suite 1100, Newport Beach, CA 92660; Telephone: 714-926-0015; Fax: 949-721-6650; e-mail: jgorbenko@aestheticimages.md.
Skin Enhancement Clinics & Technology Inc. Releases First Executive ReportPosts: 902 | Registered: Feb 2004
| IP: Logged |
posted
Skin Enhancement Clinics & Technology, Inc. "Aesthetic Images" is currently the only publicly-traded company that specializes in building and operating Medical Spas and providing Medical Spa services to both professionals and spa customers. The company strives to be the standard bearer for the Medical Spa industry in all facets of this new dimension of patient care and treatment.
Posts: 902 | Registered: Feb 2004
| IP: Logged |
posted
Skin Enhancement Clinics & Technology Medical Director, Brett Lehocky, M.D., Announces Services for Medical Spa in Corona, Calif. 4/22/2005 11:40:44 AM
LAS VEGAS, Apr 22, 2005 (PRIMEZONE via COMTEX) -- Skin Enhancement Clinics & Technology, Inc.'s (Pink Sheets:SCTG), dba Aesthetic Images, Brett Lehocky, M.D., a Board Certified Plastic Surgeon, states, "Aesthetic Images is offering a full scope of safe and proven non-invasive cosmetic and rejuvenation services. We are committed to provide the widest variety and most up to date list of services in this health care sector. We are continually educating ourselves to provide the best and most wholesome care available in the industry."
All services will be delivered under the supervision of board certified plastic surgeons. A summary of the services provided are as follows: Botox administration, Collagen and other dermal fillers administration, Laser and other light based therapy for: (a) skin rejuvenation, (b) brown spot removal, (c) red spot and spider vein removal, (d) acne, and (e) hair removal; Sclerotherapy, Medical skin care products (available by prescription only), Microdermabrasion, Facial peels, Professional aesthetician services, Oxygen therapy, Massage therapy, Teeth whitening, Spray on tanning, Vitamins and other Anti-aging products.
For further information regarding SCTG.PK contact Jamie Gorbenko, VP of Marketing, at SCTG's executive offices located at 630 Newport Center Drive, Suite 1100, Newport Beach, California 92660. Telephone: (714) 926-0015. Fax: (949) 721-6650. Email: jgorbenko@aestheticimages.md.
Safe Harbor Statement under the 1995 Private Securities Litigation Reform Act: Statements contained in this document which are not historical fact are forward-looking statements based upon management's current expectations that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements.
SOURCE: Skin Enhancement Clinics & Technology, Inc.
Skin Enhancement Clinics & Technology, Inc. Jamie Gorbenko, VP of Marketing (714) 926-0015
Posts: 902 | Registered: Feb 2004
| IP: Logged |
<coins4us>
unregistered
posted
company official says brokers will soon become involved...meetings with market movers to start next week.
IP: Logged |
<cashflow>
unregistered
posted
Very interesting company, couple of months will tell the story. In the mean time I'll buy a few thou.
IP: Logged |
<inkspots>
unregistered
posted
I'll pick up 5k just in case the news mid-week bumps the pps.
IP: Logged |
Skin Enhancement Clinics & Technology, Inc.'s (Pink Sheets:SCTG) President, Mr. Bruce Brandt, delivered a message today describing the company's approach to become a choice brand of medical spa within the industry.
"As a young company we have focused our attention on obtaining the ideal blend of attributes which are inherent to many of those business models whose success we aspire to emulate," explained Mr. Brandt. "Our company began with a vision to be a discriminating player in the extremely successful medical spa business. Rather than mimic the traditional Med-Spa model, we chose to pioneer a new corporate owned concept that allows SCTG to multiply the success from our premier Med-Spa in Corona, California, to numerous other locations throughout the country offering similar unique demographics.
"Our success as a company is building on a recipe that includes the following key ingredients: prime locations with solid demographics, board certified physicians and qualified medical staff, employee owners, the latest therapies for medical and spa related procedures, plus a highly qualified and engaged management team.
"Based on the recent successful launching of our stock (SCTG) on the Pink Sheets, clearly we are not alone in our vision. Our first Med-Spa in Corona will be the trademark we utilize to brand our other facilities throughout the country. This branding will allow us to capitalize on a proven success while maintaining the unique nature of each new location's distinguishing characteristics.
"The clients for medical procedures will receive the most current and innovative services available in the cosmetic healthcare arena administered through the care of our highly qualified medical staff. Clients for the spa services are promised to be indulged in the latest techniques to ensure a totally relaxing experience in an environment dedicated to complete stress relief."
For further information regarding SCTG contact Jamie Gorbenko, VP of Marketing, at SCTG's executive offices located at 630 Newport Center Drive, Suite 1100, Newport Beach, California 92660. Telephone: 714-926-0015. Fax: 949-721-6650. Email: jgorbenko@aestheticimages.md. The company website is www.aestheticimages.md.
Safe Harbor Statement under the 1995 Private Securities Litigation Reform Act: Statements contained in this document which are not historical fact are forward-looking statements based upon management's current expectations that are subject to risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by forward-looking statements.
Posts: 902 | Registered: Feb 2004
| IP: Logged |
posted
Happy to see the news did not attract "traders" and focused on the intrinsic value of the investment.
Posts: 902 | Registered: Feb 2004
| IP: Logged |
posted
SKIN ENHANCEMENT CLINICS AND TECHNOLOGY, INC. 7,865,000 SHARES OF COMMON STOCK
Skin Enhancement Clinics and Technology, Inc., a Nevada corporation, ("Skin Enhancement") is offering to sell 6,000,000 shares of its common stock on a self-underwritten basis at an offering price of $0.50 per share. There is no minimum number of shares that must be sold in this offering. This is the initial public offering of shares of its common stock. This offering will close whenever all of the shares are sold or twenty months after the effective date of this prospectus, whichever is sooner.
The selling shareholders named in this prospectus are offering 1,865,000 shares of common stock at an offering price of $0.50 per share. If the shares are quoted in the future on the Over The Counter Bulletin Board or some exchange, selling shareholders may sell shares at market price with the exception of 726,900 of the selling shareholder shares which are being offered by affiliates of Skin Enhancement. These affiliate shares will retain the offering price of $0.50 per share. Skin Enhancement will not receive any proceeds from shares sold by selling shareholders.
Our common stock is currently trading in the Pink Sheets under the symbol SCTG.
Offering Commissions Proceeds to Skin Proceeds to Enhancement from its self-underwritten offering before expenses selling Price (2) shareholders ------------------------------------ ------------ ----------------- --------------------------- -------------------
Per Share in Offering by Skin $0.50 $0.05 (1) $0.45 Enhancement
Per Share in Offering by Selling Shareholders $0.50 $0.00 $0.50 Totals for Offering by Skin Enhancement $3,000,000 $300,000 (1) $2,700,000 (2) Totals for Offering by Selling Shareholders $932,500 $0.00 $932,500 ------------------------------------ ------------ ----------------- --------------------------- -------------------
(1) The offering by Skin Enhancement will be self-underwritten unless it is determined at a later time to sell the offering through the use of underwriters. The table sets forth commission amounts assuming underwriters are used. (2) Offering expenses are estimated to be $50,000.00 which will leave Skin Enhancement proceeds of $2,650,000.00 if all shares offered by Skin Enhancement are sold and underwriters are used to sell the offering.
The purchase of the securities offered through this prospectus involves a high degree of risk. See section entitled "Risk Factors" on pages 3 through 5.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus. Any representation to the contrary is a criminal offense.
These shares are part of the original OS and are non-dilutive.
Posts: 902 | Registered: Feb 2004
| IP: Logged |
posted
Company will release positive news this friday. Construction of the brand new facility is on course.
Posts: 902 | Registered: Feb 2004
| IP: Logged |